Bionano Genomics (NASDAQ: BNGO), based out of San Diego, saw its shares sink 13.32% to $0.51 at 14:42 EST Friday afternoon; this represents a steep turn from their upward trend seen last session and coincided with a minor uptick on NASDAQ of 0.41% to $1,017.08, as investors seek a return from three straight sessions of losses.
Brief Overview of Bionano Stock Behavior
Bionano’s stock has shown great volatility recently, reaching its 52-week high of $4.35 before plunging 86.47 percent to close at $0.59 last Friday – providing insight into its risk and reward dynamics, which may prove advantageous to investors seeking high growth opportunities.
Products and Services Offered by Bionano Genomics
Bionano Genomics specializes in offering genome analysis solutions with comprehensive software that offers data visualization of casual variants. Utilizing Saphyr technology for structural variation analysis, Bionano Genomics serves as a key partner in understanding genetic variation and function.
Financial Performance of Bionano
Bionano’s trailing twelve-month earnings per share (EPS) of $0.45 indicates weak profitability trends. Furthermore, Bionano’s return on equity (ROE), an indicator of financial health that measures profit relative to equity owned by its shareholders, stands at negative 51.51% for this same period – suggesting it struggles to generate profit relative to shareholder equity owned.
Bionano’s Prospects
Bionano’s future could be dictated by its innovative genetic solutions; however, financial measures indicate an insufficient margin for profitability. Investors interested in Bionano should carefully weigh its growth potential against financial risks that come with negative EPS and ROE values.
More news about Bionano Genomics (BNGO).
